Lipocine Inc expected to post a loss of 3 cents a share - Earnings Preview

Lipocine

04/11/2022 19:38

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 8
(estimated). 
    * The Salt Lake City Utah-based  company is expected to
report  a
1,170.5% increase in revenue to $698.67 thousand from $54.99
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lipocine Inc is for
a
loss of 3 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$2.5​, above​ its last closing price of $0.40. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.04       -0.04      -0.03     Beat    25
 Mar. 31 2022  0.00        -0.02      -0.04     Missed  -100
 Dec. 31 2021  0.07        -0.01      0.15      Beat    1,600​
 Sep. 30 2021  -0.04       -0.04      -0.03     Beat    29.4
 ​​Jun.        -0.05       -0.05      -0.03     Beat    40
 30 2021                                                
 Mar. 31 2021  -0.05       -0.05      -0.04     Beat    20​
 Dec. 31 2020  -0.07       -0.06      -0.06     Met     5.3
 Sep. 30 2020  -0.06       -0.06      -0.07     Missed  -16.7
 This summary was machine generated November 4 at 19:38 GMT.  All
figures in US dollars  unless otherwise stated